Ropeginterferon alfa-2b (P1101)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Ropeginterferon alfa-2b (P1101), covering 2022-01-18 to 2025-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance [Phase 3]